Akorn Announces Completion of FDA Re-inspection of Decatur Facility
Dec 12, 2016 12:00 pm UTC| Business
LAKE FOREST, Ill., Dec. 12, 2016 -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) conducted a re-inspection of its Decatur,...
Calithera Biosciences Announces Key Management Changes
Dec 12, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Dec. 12, 2016 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, announced that William D. Waddill...
Flexion Therapeutics Submits New Drug Application for Zilretta™ to Treat Knee Osteoarthritis Pain
Dec 12, 2016 12:00 pm UTC| Business
BURLINGTON, Mass., Dec. 12, 2016 -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for its lead investigational...
Dec 12, 2016 12:00 pm UTC| Business
IRVING, Texas, Dec. 12, 2016 -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA) (“Reata”), a clinical-stage biopharmaceutical company, today announced that, due to adverse market conditions, it has requested withdrawal of its...
Immunomedics Announces Novel Immuno-Oncology Program Targeting Trop-2-Expressing Cancers
Dec 12, 2016 12:00 pm UTC| Business
-- Preclinical Studies Presented at 2016 San Antonio Breast Cancer Symposium (SABCS) ---- Updated Phase 2 Results with Sacituzumab Govitecan (IMMU-132) in Metastatic Triple-Negative Breast Cancer also Reported ---- Full...
CONE Midstream To Participate In CONSOL Energy Analyst Day
Dec 12, 2016 12:00 pm UTC| Business
CANONSBURG, Pa., Dec. 12, 2016 -- CONE Midstream Partners LP (NYSE:CNNX) today announced that members of its management team will make a presentation during a breakout session at the CONSOL Energy Analyst Day event on...
Dec 12, 2016 12:00 pm UTC| Business
RA’ANANA, Israel and NEW YORK, Dec. 12, 2016 -- UroGen Pharma Ltd., a privately held, clinical stage biopharmaceutical company, today announced the acceptance of its Investigational New Drug (IND) application by the...